Wednesday's agenda - Lloyds is first big bank to report
Lloyds (LON:LLOY) gets the banking reporting ball rolling on Wednesday as it is the first of three of the 'big four' reporting this week.
Company
GSK PLC
LON:GSK
GSK PLC will be a fully focused biopharma company following the demerger of its world-leading consumer healthcare business, Haleon, in July 2022. The company will prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease.
746 stories · page 36 of 38
Week Ahead: Banking sweepstakes
Three of the big four banks report this week, while the big three integrated oil majors also weigh in.
Week Ahead: Banking sweepstakes
Three of the big four banks report this week, while the big three integrated oil majors also weigh in.
Archive
JP Morgan Cazenove lifts target on Glencore
Two heavyweights came together on Monday, with JP Morgan Cazenove posting a note on much-in-the news miner and trader Glencore.
Investments and investor services
FTSE 100 regains ground as miners rise
The FTSE 100 ended 1.6%, or 96.4 points higher at 6,032.
London shares motor ahead as Volkswagen panic eases
A revival in mining and automotive industry shares lifted indices
Glaxosmithkline reports positive results from HIV drug tests
Data showed switching to once-daily Triumeq maintains HIV viral suppression
Investments and investor services
Crest Nicholson is Goldman's top pick in midst of housing sector's results season
It seems the housing sector has been bouncing back since the current decade began, but brokers seem to agree there is further to go.
Risers & Fallers: Ryanair, Horizon Discovery, ANGLE, Morrisons and GlaxoSmithKline
Below are the main news-driven share price movements at 4pm.
Woodford fund proving a summer favourite for investors
Bio and pharma holdings keep Woodford on top with other healthcare funds also doing well.
Archive
FTSE 100 crashes to eight month low
The top share index fell for the ninth day in a row and finished down 5.5% on the week.
Investments and investor services
FTSE 100 hit by double whammy from China and Greece
It's not quiet a triple digit fall - yet - for Footsie, but it is mighty close.
FTSE 100 falls for ninth day in a row
It's looking like a total capitulation by the bulls as fears grow for Asia-Pacific economic growth prospect
Footsie falls on disappointing Chinese data and Greek chaos
Index drops 47 points as Greece sets date for fresh elections
Risers & Fallers including Marechale Capital, Photonstar, Premier Oil, Glaxo, Fidelity China...
Below are the main new driven share price movements at 4pm.
GlaxoSmithKline sells MS drug rights to Novartis for US$1bn
Deal leaves Novartis as the owner of rights to ofatumumab in all indications